| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:69132 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BRCA1 mRNA | CTD | PMID:22079256 |
| (S)-nicotine | decreases expression | ISO | RGD:69132 | 6480464 | Nicotine results in decreased expression of BRCA1 mRNA | CTD | PMID:18247414 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | 2,2',3',4,4',5-hexachlorobiphenyl inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA]; more ... | CTD | PMID:12473173 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 protein] | CTD | PMID:20631324 PMID:22197621 |
| 17beta-estradiol | increases expression | ISO | RGD:69132 | 6480464 | Estradiol results in increased expression of BRCA1 protein | CTD | PMID:20631324 PMID:22197621 |
| 17beta-estradiol | increases expression | ISO | RGD:69132 | 6480464 | Estradiol results in increased expression of BRCA1 mRNA | CTD | PMID:12473173 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 protein]]; more ... | CTD | PMID:20631324 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | [[Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] promotes the reaction [AHR protein binds to BRCA1 promoter]] inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA]; more ... | CTD | PMID:20631324 PMID:20631324 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:12473173 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:69132 | 6480464 | Estradiol results in increased expression of BRCA1 protein | CTD | PMID:20631324 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | Estradiol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]] | CTD | PMID:16489025 PMID:20631324 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | PD 98059 inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:20206645 |
| 17beta-estradiol | increases expression | ISO | RGD:69132 | 6480464 | Estradiol results in increased expression of BRCA1 mRNA | CTD | PMID:12473173 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:12473173 PMID:20206645 |
| 17beta-estradiol | increases expression | ISO | RGD:69132 | 6480464 | Estradiol results in increased expression of BRCA1 mRNA | CTD | PMID:12473173 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:12473173 PMID:16489025 |
| 17beta-estradiol | increases expression | ISO | RGD:69132 | 6480464 | Estradiol results in increased expression of BRCA1 mRNA | CTD | PMID:12473173 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:16489025 PMID:12473173 |
| 17beta-estradiol | increases expression | ISO | RGD:69132 | 6480464 | Estradiol results in increased expression of BRCA1 mRNA | CTD | PMID:17266178 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | Estradiol promotes the reaction [ESR1 protein binds to CREBBP protein binds to BRCA1 protein] | CTD | PMID:16417649 |
| 17beta-estradiol | affects localization | ISO | RGD:69132 | 6480464 | Estradiol affects the localization of BRCA1 protein | CTD | PMID:16061635 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | BRCA1 protein promotes the reaction [indole-3-carbinol inhibits the reaction [Estradiol results in increased activity of ESR1 protein]] | CTD | PMID:11110848 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | BRCA1 protein affects the reaction [Estradiol promotes the reaction [ESR1 protein binds to NCOA3 protein]]; more ... | CTD | PMID:18997820 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69132 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA]; more ... | CTD | PMID:16489025 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | RGD:69132 | 6480464 | Metribolone results in increased expression of BRCA1 mRNA | CTD | PMID:17010196 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:69132 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:12473173 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10246 | 6480464 | [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of BRCA1 mRNA | CTD | PMID:21167638 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases methylation | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin results in increased methylation of BRCA1 promoter | CTD | PMID:22197621 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BRCA1 protein | CTD | PMID:20631324 PMID:22197621 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BRCA1 mRNA | CTD | PMID:22197621 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter] | CTD | PMID:16489025 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BRCA1 protein]; more ... | CTD | PMID:20631324 PMID:22197621 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]]; more ... | CTD | PMID:22197621 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:12473173 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BRCA1 protein | CTD | PMID:20631324 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | Estradiol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]] | CTD | PMID:16489025 PMID:20631324 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | [[Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] promotes the reaction [AHR protein binds to BRCA1 promoter]] inhibits the reaction [Estradiol results in increased expression of BRCA1 protein]; more ... | CTD | PMID:20631324 PMID:20631324 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin affects the expression of BRCA1 mRNA | CTD | PMID:22298810 PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | AHR protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 protein]]; more ... | CTD | PMID:20631324 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of BRCA1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin affects the expression of BRCA1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:12473173 PMID:16489025 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | BRCA1 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] | CTD | PMID:16567799 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10246 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BRCA1 mRNA | CTD | PMID:19465110 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:16489025 PMID:12473173 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Estradiol] promotes the reaction [HDAC1 protein binds to BRCA1 promoter]; more ... | CTD | PMID:16489025 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | ARNT protein affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [BRCA1 protein binds to CYP1B1 promoter]]; more ... | CTD | PMID:16567799 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69132 | 6480464 | alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased activity of BRCA1 protein]; more ... | CTD | PMID:18259752 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of BRCA1 mRNA | CTD | PMID:19167416 |
| 2-butoxyethanol | increases expression | ISO | RGD:10246 | 6480464 | n-butoxyethanol results in increased expression of BRCA1 mRNA | CTD | PMID:19812364 |
| 2-methylcholine | affects expression | ISO | RGD:69132 | 6480464 | beta-methylcholine affects the expression of BRCA1 mRNA | CTD | PMID:21179406 |
| 2-naphthylamine | decreases expression | ISO | RGD:69132 | 6480464 | 2-Naphthylamine results in decreased expression of BRCA1 mRNA | CTD | PMID:18247414 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:69132 | 6480464 | Methylcholanthrene promotes the reaction [AHR protein binds to BRCA1 protein] | CTD | PMID:18259752 |
| 3-methylcholanthrene | increases expression | ISO | RGD:10246 | 6480464 | Methylcholanthrene results in increased expression of BRCA1 mRNA | CTD | PMID:20713471 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:10246 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BRCA1 mRNA | CTD | PMID:21167638 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:10246 | 6480464 | [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of BRCA1 mRNA | CTD | PMID:21167638 |
| 5-aza-2'-deoxycytidine | affects localization | ISO | RGD:69132 | 6480464 | decitabine affects the localization of BRCA1 protein modified form | CTD | PMID:17991895 |
| 5-fluorouracil | decreases expression | ISO | RGD:69132 | 6480464 | Fluorouracil results in decreased expression of BRCA1 mRNA | CTD | PMID:17982676 PMID:15607317 |
| 5-fluorouracil | decreases expression | ISO | RGD:69132 | 6480464 | Fluorouracil results in decreased expression of BRCA1 mRNA | CTD | PMID:15607317 PMID:17982676 |
| 5-fluorouracil | increases expression | ISO | RGD:69132 | 6480464 | Fluorouracil results in increased expression of BRCA1 mRNA | CTD | PMID:16557594 PMID:16101138 |
| 5-fluorouracil | multiple interactions | ISO | RGD:69132 | 6480464 | TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of BRCA1 mRNA] | CTD | PMID:17982676 |
| 5-fluorouracil | increases expression | ISO | RGD:69132 | 6480464 | Fluorouracil results in increased expression of BRCA1 mRNA | CTD | PMID:16101138 PMID:16557594 |
| 7,12-dimethyltetraphene | affects response to substance | ISO | RGD:69132 | 6480464 | BRCA1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene | CTD | PMID:21507987 |
| acetylsalicylic acid | decreases expression | ISO | RGD:69132 | 6480464 | Aspirin results in decreased expression of BRCA1 mRNA | CTD | PMID:20457246 PMID:20514442 |
| acetylsalicylic acid | decreases expression | ISO | RGD:69132 | 6480464 | Aspirin results in decreased expression of BRCA1 mRNA | CTD | PMID:20514442 PMID:20457246 |
| all-trans-retinoic acid | increases expression | ISO | RGD:69132 | 6480464 | Tretinoin results in increased expression of BRCA1 mRNA | CTD | PMID:16054129 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:69132 | 6480464 | Tretinoin results in decreased expression of BRCA1 mRNA | CTD | PMID:15498508 |
| all-trans-retinoic acid | increases expression | ISO | RGD:10246 | 6480464 | Tretinoin results in increased expression of BRCA1 mRNA | CTD | PMID:17198874 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of BRCA1 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69132 | 6480464 | Benzo(a)pyrene inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:16489025 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69132 | 6480464 | BRCA1 inhibits the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]; more ... | CTD | PMID:22192953 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69132 | 6480464 | Benzo(a)pyrene results in decreased expression of BRCA1 mRNA | CTD | PMID:11782367 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:69132 | 6480464 | Benzo(a)pyrene results in decreased expression of BRCA1 mRNA | CTD | PMID:11782367 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:69132 | 6480464 | Benzo(a)pyrene results in decreased expression of BRCA1 mRNA | CTD | PMID:11782367 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69132 | 6480464 | ARNT protein affects the reaction [BRCA1 protein affects the susceptibility to Benzo(a)pyrene]; more ... | CTD | PMID:21507987 |
| benzo[a]pyrene | affects response to substance | ISO | RGD:10246 | 6480464 | BRCA1 protein affects the susceptibility to Benzo(a)pyrene | CTD | PMID:21507987 |
| benzo[a]pyrene | increases expression | ISO | RGD:10246 | 6480464 | Benzo(a)pyrene results in increased expression of BRCA1 mRNA | CTD | PMID:20713471 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10246 | 6480464 | Benzo(a)pyrene results in decreased expression of BRCA1 mRNA | CTD | PMID:17942131 |
| benzo[a]pyrene | affects response to substance | ISO | RGD:69132 | 6480464 | BRCA1 protein affects the susceptibility to Benzo(a)pyrene | CTD | PMID:21507987 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69132 | 6480464 | TP53 protein promotes the reaction [Benzo(a)pyrene results in decreased expression of BRCA1 mRNA] | CTD | PMID:11782367 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69132 | 6480464 | Benzo(a)pyrene results in decreased expression of BRCA1 mRNA | CTD | PMID:20064835 more ... |
| beta-hexachlorocyclohexane | multiple interactions | ISO | RGD:69132 | 6480464 | fulvestrant inhibits the reaction [beta-hexachlorocyclohexane results in increased expression of BRCA1 mRNA]; more ... | CTD | PMID:20206645 |
| beta-hexachlorocyclohexane | increases expression | ISO | RGD:69132 | 6480464 | beta-hexachlorocyclohexane results in increased expression of BRCA1 mRNA | CTD | PMID:20206645 |
| bisphenol A | increases methylation | ISO | RGD:69132 | 6480464 | bisphenol A results in increased methylation of BRCA1 gene | CTD | PMID:22258036 |
| bisphenol A | increases expression | ISO | RGD:69132 | 6480464 | bisphenol A results in increased expression of BRCA1 mRNA | CTD | PMID:22576693 |
| bisphenol A | increases response to substance | ISO | RGD:10246 | 6480464 | BRCA1 gene mutant form results in increased susceptibility to bisphenol A | CTD | PMID:20868731 |
| bisphenol A | affects response to substance | ISO | RGD:69132 | 6480464 | BRCA1 protein affects the susceptibility to bisphenol A | CTD | PMID:20868731 |
| bisphenol A | multiple interactions | ISO | RGD:69132 | 6480464 | BRCA1 protein affects the reaction [bisphenol A results in increased activity of ESR1 protein] | CTD | PMID:20868731 |
| bisphenol A | decreases expression | ISO | RGD:69132 | 6480464 | bisphenol A results in decreased expression of BRCA1 mRNA | CTD | PMID:16029874 |
| cadmium atom | decreases expression | ISO | RGD:69132 | 6480464 | Cadmium results in decreased expression of BRCA1 mRNA; more ... | CTD | PMID:20049202 |
| calcitriol | multiple interactions | ISO | RGD:69132 | 6480464 | Calcitriol promotes the reaction [Testosterone results in decreased expression of BRCA1 mRNA]; more ... | CTD | PMID:21592394 |
| calcitriol | decreases expression | ISO | RGD:69132 | 6480464 | Calcitriol results in decreased expression of BRCA1 mRNA | CTD | PMID:21592394 |
| camptothecin | decreases expression | ISO | RGD:69132 | 6480464 | Camptothecin results in decreased expression of BRCA1 mRNA | CTD | PMID:10344722 |
| carboplatin | decreases activity | ISO | RGD:69132 | 6480464 | Carboplatin results in decreased activity of BRCA1 protein | CTD | PMID:20878461 |
| choline | multiple interactions | ISO | RGD:10246 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BRCA1 mRNA | CTD | PMID:20938992 |
| cisplatin | multiple interactions | ISO | RGD:69132 | 6480464 | BRCA1 mutant form promotes the reaction [RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased activity of and results in increased phosphorylation of CHEK1 protein]]]; more ... | CTD | PMID:21875941 |
| cisplatin | multiple interactions | ISO | RGD:69132 | 6480464 | ESR2 protein inhibits the reaction [Cisplatin results in increased expression of BRCA1 mRNA]; more ... | CTD | PMID:20623183 |
| cisplatin | increases expression | ISO | RGD:69132 | 6480464 | Cisplatin results in increased expression of BRCA1 mRNA; more ... | CTD | PMID:20623183 |
| cisplatin | decreases response to substance | ISO | RGD:69132 | 6480464 | BRCA1 results in decreased susceptibility to Cisplatin | CTD | PMID:21633166 PMID:21854619 |
| cisplatin | decreases response to substance | ISO | RGD:69132 | 6480464 | BRCA1 protein results in decreased susceptibility to Cisplatin | CTD | PMID:20603439 |
| cisplatin | increases phosphorylation | ISO | RGD:10246 | 6480464 | Cisplatin results in increased phosphorylation of BRCA1 protein | CTD | PMID:22006019 |
| cisplatin | increases expression | ISO | RGD:10246 | 6480464 | Cisplatin results in increased expression of BRCA1 mRNA | CTD | PMID:21151649 |
| cisplatin | decreases response to substance | ISO | RGD:10246 | 6480464 | BRCA1 results in decreased susceptibility to Cisplatin | CTD | PMID:21771338 |
| cisplatin | decreases activity | ISO | RGD:69132 | 6480464 | Cisplatin results in decreased activity of BRCA1 protein | CTD | PMID:20878461 |
| cisplatin | decreases response to substance | ISO | RGD:69132 | 6480464 | BRCA1 results in decreased susceptibility to Cisplatin | CTD | PMID:21854619 PMID:21633166 |
| cisplatin | multiple interactions | ISO | RGD:69132 | 6480464 | vorinostat inhibits the reaction [BRCA1 results in decreased susceptibility to Cisplatin] | CTD | PMID:21854619 |
| cobalt dichloride | decreases expression | ISO | RGD:69132 | 6480464 | cobaltous chloride results in decreased expression of BRCA1 mRNA | CTD | PMID:19376846 |
| copper(2+) sulfate | affects expression | ISO | RGD:69132 | 6480464 | Copper Sulfate affects the expression of BRCA1 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | ISO | RGD:69132 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of BRCA1 mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | ISO | RGD:69132 | 6480464 | Coumestrol results in increased expression of BRCA1 mRNA | CTD | PMID:19167446 |
| crocidolite asbestos | affects expression | ISO | RGD:69132 | 6480464 | Asbestos, Crocidolite affects the expression of BRCA1 mRNA | CTD | PMID:17331233 |
| cycloheximide | multiple interactions | ISO | RGD:69132 | 6480464 | Cycloheximide inhibits the reaction [Nitrogen Mustard Compounds results in decreased expression of BRCA1 mRNA] | CTD | PMID:10344722 |
| cyclosporin A | decreases expression | ISO | RGD:10246 | 6480464 | Cyclosporine results in decreased expression of BRCA1 mRNA | CTD | PMID:17942131 |
| cyclosporin A | decreases expression | ISO | RGD:69132 | 6480464 | Cyclosporine results in decreased expression of BRCA1 mRNA | CTD | PMID:21632981 |
| cyclosporin A | decreases expression | ISO | RGD:10246 | 6480464 | Cyclosporine results in decreased expression of BRCA1 mRNA | CTD | PMID:19770486 PMID:17942131 |
| cyclosporin A | decreases expression | ISO | RGD:10246 | 6480464 | Cyclosporine results in decreased expression of BRCA1 mRNA | CTD | PMID:17942131 PMID:19770486 |
| daidzein | increases expression | ISO | RGD:69132 | 6480464 | daidzein results in increased expression of BRCA1 mRNA | CTD | PMID:17266178 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:69132 | 6480464 | dasatinib results in decreased expression of BRCA1 mRNA | CTD | PMID:20579391 |
| DDE | increases expression | ISO | RGD:69132 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of BRCA1 mRNA | CTD | PMID:20206645 |
| DDE | multiple interactions | ISO | RGD:69132 | 6480464 | fulvestrant inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BRCA1 mRNA] | CTD | PMID:20206645 |
| diamminedichloroplatinum | decreases activity | ISO | RGD:69132 | 6480464 | transplatin results in decreased activity of BRCA1 protein | CTD | PMID:20878461 |
| diarsenic trioxide | increases expression | ISO | RGD:69132 | 6480464 | arsenic trioxide results in increased expression of BRCA1 mRNA | CTD | PMID:20458559 |
| dibenzofuran | decreases expression | EXP | | 6480464 | dibenzofuran analog results in decreased expression of BRCA1 mRNA | CTD | PMID:20566336 |
| dibutyl phthalate | decreases expression | ISO | RGD:10246 | 6480464 | Dibutyl Phthalate results in decreased expression of BRCA1 mRNA | CTD | PMID:21266533 |
| dioxygen | decreases expression | ISO | RGD:69132 | 6480464 | Oxygen deficiency results in decreased expression of BRCA1 protein | CTD | PMID:17599377 |
| disodium selenite | decreases expression | ISO | RGD:69132 | 6480464 | Sodium Selenite results in decreased expression of BRCA1 mRNA | CTD | PMID:10344722 |
| doxorubicin | decreases expression | ISO | RGD:69132 | 6480464 | Doxorubicin results in decreased expression of BRCA1 mRNA | CTD | PMID:10344722 PMID:15607317 |
| doxorubicin | decreases expression | ISO | RGD:69132 | 6480464 | Doxorubicin results in decreased expression of BRCA1 mRNA | CTD | PMID:10344722 more ... |
| doxorubicin | decreases expression | ISO | RGD:69132 | 6480464 | Doxorubicin results in decreased expression of BRCA1 mRNA | CTD | PMID:15607317 PMID:10344722 |
| etoposide | multiple interactions | ISO | RGD:69132 | 6480464 | BRCA1 protein mutant form inhibits the reaction [Etoposide results in increased expression of CDK2 protein]; more ... | CTD | PMID:16417649 |
| etoposide | decreases expression | ISO | RGD:69132 | 6480464 | Etoposide results in decreased expression of BRCA1 mRNA | CTD | PMID:15607317 |
| folic acid | multiple interactions | ISO | RGD:10246 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BRCA1 mRNA | CTD | PMID:20938992 |
| fulvestrant | multiple interactions | ISO | RGD:69132 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:12473173 |
| fulvestrant | multiple interactions | ISO | RGD:69132 | 6480464 | fulvestrant inhibits the reaction [beta-hexachlorocyclohexane results in increased expression of BRCA1 mRNA]; more ... | CTD | PMID:20206645 |
| fulvestrant | multiple interactions | ISO | RGD:69132 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:12473173 PMID:20206645 |
| fulvestrant | decreases expression | ISO | RGD:69132 | 6480464 | fulvestrant results in decreased expression of BRCA1 mRNA | CTD | PMID:20206645 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of BRCA1 mRNA | CTD | PMID:22079235 |
| genistein | increases expression | ISO | RGD:69132 | 6480464 | Genistein results in increased expression of BRCA1 protein | CTD | PMID:16434996 |
| genistein | increases expression | ISO | RGD:69132 | 6480464 | Genistein results in increased expression of BRCA1 mRNA | CTD | PMID:16434996 PMID:17266178 |
| genistein | multiple interactions | ISO | RGD:69132 | 6480464 | [indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA1 protein | CTD | PMID:16434996 |
| genistein | increases expression | ISO | RGD:69132 | 6480464 | Genistein results in increased expression of BRCA1 mRNA | CTD | PMID:17266178 PMID:16434996 |
| hydrogen peroxide | decreases response to substance | ISO | RGD:69132 | 6480464 | BRCA1 protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:15520196 |
| hydrogen peroxide | increases expression | ISO | RGD:69132 | 6480464 | Hydrogen Peroxide results in increased expression of BRCA1 mRNA | CTD | PMID:22539617 |
| indole-3-methanol | multiple interactions | ISO | RGD:69132 | 6480464 | BRCA1 protein promotes the reaction [indole-3-carbinol inhibits the reaction [Estradiol results in increased activity of ESR1 protein]] | CTD | PMID:11110848 |
| indole-3-methanol | increases expression | ISO | RGD:69132 | 6480464 | indole-3-carbinol results in increased expression of BRCA1 protein | CTD | PMID:11110848 PMID:16434996 |
| indole-3-methanol | increases expression | ISO | RGD:69132 | 6480464 | indole-3-carbinol results in increased expression of BRCA1 protein | CTD | PMID:16434996 PMID:11110848 |
| indole-3-methanol | increases expression | ISO | RGD:69132 | 6480464 | indole-3-carbinol results in increased expression of BRCA1 mRNA | CTD | PMID:16434996 |
| indole-3-methanol | multiple interactions | ISO | RGD:69132 | 6480464 | indole-3-carbinol promotes the reaction [AHR protein binds to BRCA1 protein] | CTD | PMID:18259752 |
| indole-3-methanol | multiple interactions | ISO | RGD:69132 | 6480464 | [indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA1 protein | CTD | PMID:16434996 |
| L-methionine | multiple interactions | ISO | RGD:10246 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BRCA1 mRNA | CTD | PMID:20938992 |
| leptomycin B | decreases expression | ISO | RGD:69132 | 6480464 | leptomycin B results in decreased expression of BRCA1 mRNA | CTD | PMID:20803015 |
| leptomycin B | multiple interactions | ISO | RGD:69132 | 6480464 | [leptomycin B co-treated with TP53 gene mutant form] results in decreased expression of BRCA1 mRNA | CTD | PMID:20803015 |
| lucanthone | decreases expression | ISO | RGD:69132 | 6480464 | Lucanthone results in decreased expression of BRCA1 mRNA | CTD | PMID:21148553 |
| methotrexate | multiple interactions | ISO | RGD:69132 | 6480464 | BRCA1 mutant form promotes the reaction [TP53 mutant form results in increased susceptibility to Methotrexate] | CTD | PMID:21875941 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | RGD:69132 | 6480464 | Methylnitronitrosoguanidine results in increased expression of BRCA1 mRNA | CTD | PMID:12634122 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:10246 | 6480464 | Diethylnitrosamine results in increased expression of BRCA1 mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10246 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of BRCA1 mRNA] | CTD | PMID:17854601 |
| O-methyleugenol | decreases expression | EXP | | 6480464 | methyleugenol results in decreased expression of BRCA1 mRNA | CTD | PMID:21659616 |
| oxaliplatin | decreases activity | ISO | RGD:69132 | 6480464 | oxaliplatin results in decreased activity of BRCA1 protein | CTD | PMID:20878461 |
| paclitaxel | decreases expression | ISO | RGD:69132 | 6480464 | Paclitaxel results in decreased expression of BRCA1 mRNA | CTD | PMID:15607317 |
| paracetamol | affects expression | ISO | RGD:10246 | 6480464 | Acetaminophen affects the expression of BRCA1 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:69132 | 6480464 | Acetaminophen results in increased expression of BRCA1 mRNA | CTD | PMID:22230336 |
| paracetamol | decreases expression | ISO | RGD:10246 | 6480464 | Acetaminophen results in decreased expression of BRCA1 mRNA | CTD | PMID:17942131 |
| paraquat | decreases response to substance | ISO | RGD:69132 | 6480464 | BRCA1 protein results in decreased susceptibility to Paraquat | CTD | PMID:15520196 |
| phenobarbital | affects expression | ISO | RGD:69132 | 6480464 | Phenobarbital affects the expression of BRCA1 mRNA | CTD | PMID:19159669 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10246 | 6480464 | [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BRCA1 mRNA | CTD | PMID:16368122 |
| pirinixic acid | multiple interactions | ISO | RGD:10246 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of BRCA1 mRNA] | CTD | PMID:17950772 |
| pirinixic acid | increases expression | ISO | RGD:10246 | 6480464 | pirinixic acid results in increased expression of BRCA1 mRNA | CTD | PMID:17950772 |
| potassium bromate | increases expression | ISO | RGD:69132 | 6480464 | potassium bromate results in increased expression of BRCA1 mRNA | CTD | PMID:22539617 |
| quercetin | increases expression | ISO | RGD:69132 | 6480464 | Quercetin results in increased expression of BRCA1 mRNA | CTD | PMID:14715546 |
| quercetin | increases expression | ISO | RGD:69132 | 6480464 | Quercetin results in increased expression of BRCA1 mRNA | CTD | PMID:14715546 PMID:21632981 |
| resveratrol | increases expression | ISO | RGD:69132 | 6480464 | resveratrol results in increased expression of BRCA1 mRNA | CTD | PMID:15149879 |
| resveratrol | multiple interactions | ISO | RGD:69132 | 6480464 | [Estradiol co-treated with resveratrol] inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]]; more ... | CTD | PMID:20631324 |
| resveratrol | multiple interactions | ISO | RGD:69132 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BRCA1 protein] | CTD | PMID:20631324 PMID:22197621 |
| resveratrol | multiple interactions | ISO | RGD:69132 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]]; more ... | CTD | PMID:22197621 |
| resveratrol | affects localization | ISO | RGD:69132 | 6480464 | resveratrol affects the localization of BRCA1 protein | CTD | PMID:19559722 |
| resveratrol | multiple interactions | ISO | RGD:69132 | 6480464 | resveratrol affects the expression of and affects the phosphorylation of BRCA1 protein | CTD | PMID:19559722 |
| resveratrol | multiple interactions | ISO | RGD:69132 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of BRCA1 mRNA | CTD | PMID:19167446 |
| rotenone | increases expression | ISO | RGD:69132 | 6480464 | Rotenone results in increased expression of BRCA1 mRNA | CTD | PMID:18191903 |
| sodium dichromate | increases expression | ISO | RGD:10246 | 6480464 | sodium bichromate results in increased expression of BRCA1 mRNA | CTD | PMID:22155349 |
| succimer | multiple interactions | ISO | RGD:10246 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRCA1 mRNA | CTD | PMID:21641980 |
| sulindac | decreases expression | ISO | RGD:69132 | 6480464 | Sulindac results in decreased expression of BRCA1 mRNA | CTD | PMID:16273229 |
| tamibarotene | decreases expression | ISO | RGD:69132 | 6480464 | Am 80 results in decreased expression of BRCA1 mRNA; more ... | CTD | PMID:15498508 |
| tamoxifen | affects activity | ISO | RGD:69132 | 6480464 | BRCA1 affects the activity of Tamoxifen | CTD | PMID:15750629 |
| tamoxifen | multiple interactions | ISO | RGD:10246 | 6480464 | [Tamoxifen co-treated with BRCA1 protein mutant form] results in decreased expression of ESR1 protein | CTD | PMID:15750629 |
| tamoxifen | increases response to substance | ISO | RGD:69132 | 6480464 | BRCA1 protein results in increased susceptibility to Tamoxifen | CTD | PMID:18997820 |
| tamoxifen | multiple interactions | ISO | RGD:69132 | 6480464 | BRCA1 protein affects the reaction [Tamoxifen promotes the reaction [ESR1 protein binds to NCOR2 protein]]; more ... | CTD | PMID:18997820 |
| testosterone | multiple interactions | ISO | RGD:69132 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of BRCA1 mRNA; more ... | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:69132 | 6480464 | Testosterone results in decreased expression of BRCA1 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of BRCA1 mRNA | CTD | PMID:12734012 |
| tetrachloromethane | increases expression | ISO | RGD:10246 | 6480464 | Carbon Tetrachloride results in increased expression of BRCA1 mRNA | CTD | PMID:17484886 |
| thapsigargin | increases expression | ISO | RGD:69132 | 6480464 | Thapsigargin results in increased expression of BRCA1 protein; more ... | CTD | PMID:16434996 |
| trans-resveratrol | increases expression | ISO | RGD:69132 | 6480464 | resveratrol results in increased expression of BRCA1 mRNA | CTD | PMID:15149879 |
| trans-resveratrol | multiple interactions | ISO | RGD:69132 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]]; more ... | CTD | PMID:22197621 |
| trans-resveratrol | multiple interactions | ISO | RGD:69132 | 6480464 | [Estradiol co-treated with resveratrol] inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BRCA1 promoter]]; more ... | CTD | PMID:20631324 |
| trans-resveratrol | multiple interactions | ISO | RGD:69132 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BRCA1 protein] | CTD | PMID:20631324 PMID:22197621 |
| trans-resveratrol | affects localization | ISO | RGD:69132 | 6480464 | resveratrol affects the localization of BRCA1 protein | CTD | PMID:19559722 |
| trans-resveratrol | multiple interactions | ISO | RGD:69132 | 6480464 | resveratrol affects the expression of and affects the phosphorylation of BRCA1 protein | CTD | PMID:19559722 |
| trans-resveratrol | multiple interactions | ISO | RGD:69132 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of BRCA1 mRNA | CTD | PMID:19167446 |
| transplatin | decreases activity | ISO | RGD:69132 | 6480464 | transplatin results in decreased activity of BRCA1 protein | CTD | PMID:20878461 |
| trimellitic anhydride | increases expression | ISO | RGD:10246 | 6480464 | trimellitic anhydride results in increased expression of BRCA1 mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | ISO | RGD:69132 | 6480464 | troglitazone results in decreased expression of BRCA1 mRNA | CTD | PMID:19140230 |
| tunicamycin | increases expression | ISO | RGD:69132 | 6480464 | Tunicamycin results in increased expression of BRCA1 protein | CTD | PMID:16434996 |
| valproic acid | decreases expression | ISO | RGD:69132 | 6480464 | Valproic Acid results in decreased expression of BRCA1 mRNA | CTD | PMID:20585447 |
| vincristine | increases response to substance | ISO | RGD:69132 | 6480464 | BRCA1 gene SNP results in increased susceptibility to Vincristine | CTD | PMID:20864405 |